CYT387, a JAK-Specific Inhibitor Impedes Osteoclast Activity and Oophorectomy-Induced Osteoporosis via Modulating RANKL and ROS Signaling Pathways

Jing Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Bo Zhou(Guangxi Medical University)
Frontiers in Pharmacology
March 8, 2022
Cited by 24


Related Papers